Empowering Health, Enriching Lives
Our Vision
Ampio Pharmaceuticals is dedicated to developing and commercializing innovative pharmaceutical solutions that improve the lives of patients and address unmet medical needs. We believe in harnessing scientific advancements to deliver remarkable healthcare advancements across diverse therapeutic areas.
Our Expertise
Our team comprises seasoned professionals with proven track records in various aspects of the pharmaceutical industry. We boast expertise in:
- Product Development: Formulation development, clinical research, and manufacturing.
- Commercialization: Strategic marketing, pricing, and brand management.
- Business Development: Identifying and partnering with key stakeholders.
- Financial Management: Budgeting, capital allocation, and risk mitigation.
Our Approach
We employ a data-driven and collaborative approach to research and development, prioritizing efficiency, agility, and patient-centricity. Our commitment to transparency and accountability is reflected in our open communication and robust regulatory compliance practices.
Our Focus Areas
Ampio Pharmaceuticals is currently focused on developing and commercializing therapeutics in the following therapeutic areas:
- Neurology: Addressing central nervous system disorders with innovative medications.
- Oncology: Delivering targeted therapies to fight cancer with precision and efficacy.
- Infectious Diseases: Developing effective treatments and vaccines to combat infectious diseases.
Our Journey
Our journey has been marked by notable achievements and strategic decisions to ensure sustainable growth. In 2024, we made the strategic decision to pursue voluntary delisting from the NYSE and focus on winding down our operations. This decisive action enables us to maximize our cash position and ensure an orderly closure of our business.
Our Vision for the Future
While we are winding down our operations, we remain committed to fulfilling our responsibilities to our stakeholders. We are dedicated to collaborating with industry partners to ensure a smooth transition for our employees and ensuring fair compensation for our outstanding obligations.
Poor Performance and Mismanagement
Ampio is heavily criticized by multiple reviewers for its poor performance and management. According to the reviews, the company has been struggling for a long time, with some critics calling for the company to be shut down. Lack of Leadership is mentioned as a major issue, with some reviewers expressing frustration at the company's management team, which they believe is making poor decisions that are detrimental to the company's success.
Unfair Treatment of Shareholders
One reviewer specifically calls out the management team for prioritizing their own financial gain over the interests of shareholders. They express outrage at the company's decision to perform multiple reverse splits, which they believe has negatively impacted the stock price and the value of shareholders' investments.
Negative Sentiment
Overall, the negative sentiment towards Ampio is overwhelming, with both reviewers expressing serious discontent with the company's performance and management. The tone is one of frustration and anger, with some critics even calling for legal action against the management team.
Be the first to review Ninth Floor.
Write a Review
